Y ATLAS ANTIBODIES Trademark

Trademark Overview


On Monday, August 28, 2006, a trademark application was filed for Y ATLAS ANTIBODIES with the United States Patent and Trademark Office. The USPTO has given the Y ATLAS ANTIBODIES trademark a serial number of 78961832. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, August 21, 2015. This trademark is owned by Atlas Antibodies Aktiebolag. The Y ATLAS ANTIBODIES trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Pharmaceutical substances based on affinity reagents of immunoglobulin or non-immunoglobulin origin for cancer diagnostics, prognostics, and treatment; pharmaceutical preparations for molecular or cellular targeting, protein detection, and in-vivo imaging, mainly for cancer cells, in-vitro or in-vivo, all for medical or diagnostic purposes; biological preparations for pharmaceutical use for cancer diagnostics, prognostics, and treatment

Scientific and medical research and developments within the field of biochemistry and biotechnology, diagnostics and pharmaceutical or medical substances and preparations
y atlas antibodies

General Information


Serial Number78961832
Word MarkY ATLAS ANTIBODIES
Filing DateMonday, August 28, 2006
Status710 - CANCELLED - SECTION 8
Status DateFriday, August 21, 2015
Registration Number3566066
Registration DateTuesday, January 20, 2009
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 29, 2008

Trademark Statements


Indication of Colors claimedColor is not claimed as a feature of the mark.
Disclaimer with Predetermined Text"ANTIBODIES"
Description of MarkThe mark consists of a circle with a fading peripheral edge and a "Y" in the center.
Goods and ServicesPharmaceutical substances based on affinity reagents of immunoglobulin or non-immunoglobulin origin for cancer diagnostics, prognostics, and treatment; pharmaceutical preparations for molecular or cellular targeting, protein detection, and in-vivo imaging, mainly for cancer cells, in-vitro or in-vivo, all for medical or diagnostic purposes; biological preparations for pharmaceutical use for cancer diagnostics, prognostics, and treatment
Goods and ServicesScientific and medical research and developments within the field of biochemistry and biotechnology, diagnostics and pharmaceutical or medical substances and preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 21, 2015
Primary Code005
First Use Anywhere DateMonday, August 28, 2006
First Use In Commerce DateMonday, August 28, 2006

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, August 21, 2015
Primary Code042
First Use Anywhere DateSunday, October 29, 2006
First Use In Commerce DateSunday, October 29, 2006

Trademark Owner History


Party NameAtlas Antibodies Aktiebolag
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressStockholm 10691
SE

Party NameAtlas Antibodies Aktiebolag
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressStockholm 10691
SE

Party NameAtlas Antibodies Aktiebolag
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressStockholm 10691
SE

Trademark Events


Event DateEvent Description
Friday, August 21, 2015CANCELLED SEC. 8 (6-YR)
Tuesday, January 20, 2009REGISTERED-PRINCIPAL REGISTER
Thursday, December 18, 2008LAW OFFICE REGISTRATION REVIEW COMPLETED
Wednesday, December 17, 2008ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, December 5, 2008STATEMENT OF USE PROCESSING COMPLETE
Wednesday, November 26, 2008USE AMENDMENT FILED
Wednesday, December 3, 2008CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, November 26, 2008TEAS STATEMENT OF USE RECEIVED
Tuesday, July 22, 2008NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 29, 2008PUBLISHED FOR OPPOSITION
Wednesday, April 9, 2008NOTICE OF PUBLICATION
Tuesday, March 25, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, March 24, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 19, 2008EXAMINER'S AMENDMENT ENTERED
Wednesday, March 19, 2008NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 19, 2008EXAMINERS AMENDMENT E-MAILED
Wednesday, March 19, 2008EXAMINERS AMENDMENT -WRITTEN
Monday, October 22, 2007NOTIFICATION OF PRIORITY ACTION E-MAILED
Monday, October 22, 2007PRIORITY ACTION E-MAILED
Monday, October 22, 2007PRIORITY ACTION WRITTEN
Tuesday, October 9, 2007PREVIOUS ALLOWANCE COUNT WITHDRAWN
Friday, October 5, 2007WITHDRAWN FROM PUB - OG REVIEW QUERY
Tuesday, September 25, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, September 25, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, September 13, 2007AMENDMENT FROM APPLICANT ENTERED
Thursday, September 13, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 13, 2007ASSIGNED TO LIE
Wednesday, August 8, 2007PAPER RECEIVED
Monday, February 5, 2007NON-FINAL ACTION E-MAILED
Monday, February 5, 2007NON-FINAL ACTION WRITTEN
Monday, January 22, 2007ASSIGNED TO EXAMINER
Wednesday, September 6, 2006NOTICE OF DESIGN SEARCH CODE MAILED
Tuesday, September 5, 2006NEW APPLICATION ENTERED IN TRAM